Clinical Trial Update: Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease [Phase 2, Phase 3]

View source ↗

Summary

This document is an update on the Rio Trial evaluating ReoPro (abciximab) with peripheral arterial intervention for peripheral arterial disease, spanning Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• ReoPro (abciximab)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Arterial Occlusive Diseases | Phase 2, Phase 3 | Status: UNKNOWN